Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and… Read More »Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Dr Bill Nelson speaks with Dr Drew Pardoll, the Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, about the progress being made in empowering patient's… Read More »Cancer Matters with Dr. Bill Nelson – Cancer Immunotherapy
It’s lung cancer awareness month. Hear lung cancer expert Julie Brahmer and cancer genetics expert Victor Velculescu explain how immunotherapy is becoming a game changer… Read More »Immunotherapy for Lung Cancer
It’s Pancreatic Cancer Awareness Month, so we wanted to gather our best Kimmel Cancer Center resources for you. Learn more about cancer vaccines and other… Read More »Pancreatic Cancer Awareness Month
*Update Aug. 30, 2017 - The FDA has approved the CAR-T therapy tisagenlecleucel for certain leukemia patients. News of an FDA advisory committee that has reviewed… Read More »‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle
When doctors told Stefanie Joho that they had no options left, her sister scoured the internet to find "something" that could offer hope. She found… Read More »Stefanie Joho describes how she participated in a landmark clinical trial of immunotherapy
Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30… Read More »Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics
Johns Hopkins undergraduate student Sabrina Wang won first place in a competition among 125 students for her research on a lethal type of pediatric brain… Read More »Johns Hopkins Student Wins Top Prize For Research on Lethal Brain Tumors in Children
Jiajia Zhang was a trained oncologist in China when she read news about former Vice President Joe Biden's visit to Johns Hopkins and the launch… Read More »Training the next generation of cancer immunotherapy experts
